OpenBilldrug price receipt

NADAC week of 2026-10-14

TRANSDERM-SCOP 1 MG/3 DAY PTCH

FDA nonproprietary name: scopolamine

For 1 patch

Pharmacies pay

$11.02 filed

1 × $11.02117 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$17.67 estimated

$11.02 + $1.65 (15%) + $5.00 fee per fill = $17.67

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TRANSDERM-SCOP 1 MG/3 DAY PTCH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as scopolamine, under the trade name “Transderm Scop”.

FDA gives its dosage form as patch, extended release and its route as transdermal.

The labeler, the company named on the label, is Baxter Healthcare Corporation.

FDA’s Established Pharmacologic Class for it is Anticholinergic.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $11.02 for 1 patch (1 × $11.02117 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $4.33565 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 2 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name scopolamine with TRANSDERM-SCOP 1 MG/3 DAY PTCH.

ProductPharmacies pay per unitMedicare per unit
SCOPOLAMINE 1 MG/3 DAY PATCH
generic · patch / system / patch, extended release
$4.33565 per EA filed
eff. 2026-09-23
$11.60174 per EA filed
Part D 2024 average
TRANSDERM-SCOP 1 MG/3 DAY PTCH this page
brand · patch, extended release
$11.02117 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $11.02117 per EA filed.

Of the 23 other products in FDA’s Anticholinergic class priced per EA, 4 have a higher middle NADAC price and 19 a lower one. The one in the middle is LOMOTIL 2.5-0.025 MG TABLET, at $2.99096 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 patch?
NADAC prices this product per EA, and the FDA NDC Directory lists its 2 NDCs as dosage form “PATCH, EXTENDED RELEASE” with route “TRANSDERMAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. So the card starts at 1 patch, priced per patch, rather than guess how many make up a fill; change it to match your prescription.